Description
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
CV-65 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
| Purity | ≥70% |
|---|---|
| Formula | C14H10N2O4 |
| Formula Wt. | 270.24 |
| Chemical Name | 3,6-Dimethyl-1,8-diazaanthracene-2,7,9,10(1H,8H)-tetrone |
| IUPAC Name | 3,7-dimethyl-1,9-dihydropyrido[3,2-g]quinoline-2,5,8,10-tetrone |
| Appearance | Orange Solid |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Peptide, involved in neutrophil activation; FPR...
Minor kavalactone originally found in Piper met...
All-trans nonaprenol isoprenoid, found in Solan...
Smoothened agonist.
Antimicrobial peptide found in Hyalophora cecro...
beta-Amyloid anti-oligomer and aggregation inhi...
Endogenous peptide neurotransmitter, involved i...
Endogenous amino acid, also found in meat, dair...
FK506 analog; calcineurin inhibitor.
AurK, FLT3, Abl inhibitor.
NSAID; COX-2 inhibitor.
AT1 antagonist.
AMPK activator.
Benzimidazole; microtubule polymerization inhib...
AT-II antagonist, PPARγ/δ modulator.
GSK-3β inhibitor.
Histamine H2 inverse agonist.
Enone.
PORCN inhibitor.
Mas antagonist.